15.900
+1,27%
2026-10-19
Fundamental Analysis
100 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +212.3% | +86.0% | 3 / 3 | +113.6% | +5.23 pp | +10.33 pp | +30.7% | 0.12 | 5.14 | 210 | +113,6% | 68,2 | +213,4% | 5.14 | 6.80 | −24,4% |
| Pts | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | |||||||
Valuation annotation:Price: 15.900 (close price on 2026-10-19)EPS (TTM): 3.091
Financial charts
1.Revenue & growth
VND bn210Q2/26
1.Revenue & growth
VND bn210Q2/26
2.Profit & growth
VND bn63,8Q2/26
3.Profit mix (Penman)
VND bn275Q2/26
4.Margins & cost structure
%39.2%Q2/26
5.Returns & cash cycle
% · days35.3%Q2/26
6.Earnings quality & cash
VND bn148Q2/26
7.Asset structure
VND bn1.031Q2/26
8.Funding & debt health
VND bn · times1.031Q2/26
9.Revenue backlog
VND bn0,00Q2/26
10.Valuation
times · %5,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %871Q2/26
Adjusted EPS growth, latest quarter
192%
Average adjusted EPS growth, 3 quarters
79.2%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26